TerminatedPhase 1NCT04397679

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Barbara Ann Karmanos Cancer Institute
Principal Investigator
Michael Dominello, M.D.
Barbara Ann Karmanos Institute
Intervention
3-Dimensional Conformal Radiation Therapy(radiation)
Enrollment
2 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04397679 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials